Melanoma, Melanoma skin cancer, Skin cancer
Open
Phase 3
This trial is looking at tebentafusp for a type of eye cancer called uveal melanoma.
It is for people who have:
had surgery or radiotherapy to treat their eye cancer
an increased risk of their cancer coming back
Recruitment start: 20 November 2025
Recruitment end: 30 November 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Nathan
European Organisation for Research and Treatment of Cancer (EORTC)
Last reviewed: 19 Dec 2025
CRUK internal database number: 20021